Thus, our results provided the possible therapeutic target that elevated FIH-1 by inhibiting miR-98 results in accumulation of HIF-1-mediated adaptive cellular responses to burn-induced ischemia and upregulation of the expression of junction-associated genes that protects against burn-induced internal organ epithelial barrier dysfunction. This evidence concerns the gene HIF1A and ischemia.